FORTIS INC./ CA3495531079 /
2024-05-24 8:09:26 AM | Chg. -0.730 | Volume | Bid9:59:51 PM | Ask9:59:51 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
36.840EUR | -1.94% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 18.04 bill.EUR | - | - |
GlobeNewswire
05-23
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
05-15
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
04-24
Advisory: Fortis Inc. to Hold Teleconference on May 1 to Discuss First Quarter 2024 Results and Hold...
GlobeNewswire
04-24
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combinat...
GlobeNewswire
04-23
Maryland CareerQuest Connects Area Students with Training and Education Opportunities for Hands-On C...
GlobeNewswire
04-03
Fortis Inc. to Hold Teleconference on May 1 to Discuss First Quarter 2024 Results and Hold Annual an...
GlobeNewswire
04-02
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metast...
GlobeNewswire
03-28
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial ...
GlobeNewswire
03-19
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning
GlobeNewswire
03-13
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
03-01
Sage Transform 2024 Unveils Sage Copilot and Introduces Groundbreaking Tech Innovations, Product Enh...
GlobeNewswire
03-01
Sage Transform 2024 Unveils Sage Copilot and Introduces Groundbreaking Tech Innovations, Product Enh...
GlobeNewswire
02-01
Advisory: Fortis Inc. to Hold Teleconference and Webcast on February 9 to Discuss 2023 Annual Result...
GlobeNewswire
01-11
Fortis Inc. to Hold Teleconference and Webcast on February 9 to Discuss 2023 Annual Results
GlobeNewswire
2023-12-12
AstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccine
GlobeNewswire
2023-11-14
Perspective Therapeutics Reports Third Quarter Fiscal 2023 Results and Recent Business Highlights